Advertisement

Sepsis pp 7-24 | Cite as

Sepsis Definitions

  • Debasree Banerjee
  • Mitchell M. Levy
Chapter
Part of the Respiratory Medicine book series (RM)

Abstract

Sepsis is the tenth leading cause of death in the United States [1]. Mortality in the United States from sepsis is more than the total number of deaths caused by prostate cancer, breast cancer, and AIDS combined [2]. It causes more hospitalizations than acute myocardial infarction and has become a leading cause of hospital expenditure [3, 4]. Ninety percent of physicians feel that sepsis is a “significant financial burden on the health care system in their country” [5]. The Center for Disease Control and Prevention cite an aging population, chronic illness, invasive procedures, immunosuppressive drugs, chemotherapy, organ transplantation, antibiotic resistance, and increased awareness as causes for the increase in number of reported cases of sepsis each year in the United States. Despite the significance held by this disease in medicine it has been subject to many varying definitions over the years. The ongoing changes in the “definition” of sepsis reflect both a new emphasis on precision, needed for research, and an ever-expanding knowledge of its pathophysiology.

Keywords

Sepsis Septic shock Sepsis treatment Sepsis definitions Sepsis consensus Critical care Surviving sepsis campaign 

References

  1. 1.
    Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2010. Natl Vital Stat Rep. 2013;61(4):1–117.PubMedGoogle Scholar
  2. 2.
    National Institute of General Medical Sciences. Sepsis Fact Sheet. 2014.Google Scholar
  3. 3.
    Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–10.CrossRefPubMedGoogle Scholar
  4. 4.
    Elixhauser A, Friedman B, Stranges E. Septicemia in U.S. Hospitals, 2009: Statistical Brief #122. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Health Care Policy and Research (US); 2006.Google Scholar
  5. 5.
    Poeze M, Ramsay G, Gerlach H, Rubulotta F, Levy M. An international sepsis survey: a study of doctors’ knowledge and perception about sepsis. Crit Care. 2004;8(6):R409–13.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Geroulanos S, Douka ET. Historical perspective of the word “sepsis”. Intensive Care Med. 2006;32(12):2077.CrossRefPubMedGoogle Scholar
  7. 7.
    Bone RC, Fisher Jr CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit Care Med. 1989;17(5):389–93.CrossRefPubMedGoogle Scholar
  8. 8.
    American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20(6):864–74.Google Scholar
  9. 9.
    Lynn LA. The diagnosis of sepsis revisited—a challenge for young medical scientists in the 21st century. Patient Saf Surg. 2014;8(1):1.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Pauker SG, Kassirer JP. The threshold approach to clinical decision making. N Engl J Med. 1980;302(20):1109–17.CrossRefPubMedGoogle Scholar
  11. 11.
    Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med. 2003;29(4):530–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644–55.CrossRefPubMedGoogle Scholar
  13. 13.
    Veloso T, Neves A, Vincent JL. Are the concepts of SIRS and MODS useful in sepsis? New York: Elsevier; 2009.Google Scholar
  14. 14.
    Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26(11):1793–800.CrossRefPubMedGoogle Scholar
  15. 15.
    Mikkelsen ME, Gaieski DF. Classifying infections in the ICU: seeking certainty in an uncertain environment. Crit Care Med. 2013;41(10):2452–3.CrossRefPubMedGoogle Scholar
  16. 16.
    Klein Klouwenberg PM, Ong DS, Bos LD, de Beer FM, van Hooijdonk RT, Huson MA, et al. Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients. Crit Care Med. 2013;41(10):2373–8.CrossRefPubMedGoogle Scholar
  17. 17.
    W.O. The Evolution of Modern Medicine. 1904.Google Scholar
  18. 18.
    Vincent JL, Opal SM, Marshall JC, Tracey KJ. Sepsis definitions: time for change. Lancet. 2013;381(9868):774–5.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011;29:139–62.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Czura CJ. “Merinoff symposium 2010: sepsis”—speaking with one voice. Mol Med. 2011;17(1–2):2–3.PubMedPubMedCentralGoogle Scholar
  21. 21.
    Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–10.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Sprung CL, Sakr Y, Vincent JL, Le Gall JR, Reinhart K, Ranieri VM, et al. An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence in Acutely Ill Patients (SOAP) study. Intensive Care Med. 2006;32(3):421–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Vincent JL. Dear SIRS, I’m sorry to say that I don’t like you. Crit Care Med. 1997;25(2):372–4.CrossRefPubMedGoogle Scholar
  24. 24.
    Kaukonen KM, Bailey M, Pilcher D, Cooper DJ, Bellomo R. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med. 2015;372(17):1629–38.CrossRefPubMedGoogle Scholar
  25. 25.
    Gaieski DF, Goyal M. What is sepsis? What is severe sepsis? What is septic shock? Searching for objective definitions among the winds of doctrines and wild theories. Expert Rev Anti Infect Ther. 2013;11(9):867–71.CrossRefPubMedGoogle Scholar
  26. 26.
    Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995;273(2):117–23.CrossRefPubMedGoogle Scholar
  27. 27.
    Howell MD, Talmor D, Schuetz P, Hunziker S, Jones AE, Shapiro NI. Proof of principle: the predisposition, infection, response, organ failure sepsis staging system. Crit Care Med. 2011;39(2):322–7.CrossRefPubMedGoogle Scholar
  28. 28.
    Huh JW, Lim CM, Koh Y, Lee J, Jung YK, Seo HS, et al. Activation of a medical emergency team using an electronic medical recording-based screening system. Crit Care Med. 2014;42(4):801–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Jones L, King L, Wilson C. A literature review: factors that impact on nurses’ effective use of the Medical Emergency Team (MET). J Clin Nurs. 2009;18(24):3379–90.CrossRefPubMedGoogle Scholar
  30. 30.
    McCurdy MT, Wood SL. Rapid response systems: identification and management of the “prearrest state”. Emerg Med Clin North Am. 2012;30(1):141–52.CrossRefPubMedGoogle Scholar
  31. 31.
    Devita MA, Bellomo R, Hillman K, Kellum J, Rotondi A, Teres D, et al. Findings of the first consensus conference on medical emergency teams. Crit Care Med. 2006;34(9):2463–78.CrossRefPubMedGoogle Scholar
  32. 32.
    Churpek MM, Yuen TC, Huber MT, Park SY, Hall JB, Edelson DP. Predicting cardiac arrest on the wards: a nested case-control study. Chest. 2012;141(5):1170–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Wei WQ, Teixeira PL, Mo H, Cronin RM, Warner JL, Denny JC. Combining billing codes, clinical notes, and medications from electronic health records provides superior phenotyping performance. J Am Med Inform Assoc. 2015.Google Scholar
  34. 34.
    Jolley RJ, Sawka KJ, Yergens DW, Quan H, Jette N, Doig CJ. Validity of administrative data in recording sepsis: a systematic review. Crit Care. 2015;19:139.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Whittaker SA, Mikkelsen ME, Gaieski DF, Koshy S, Kean C, Fuchs BD. Severe sepsis cohorts derived from claims-based strategies appear to be biased toward a more severely ill patient population. Crit Care Med. 2013;41(4):945–53.CrossRefPubMedGoogle Scholar
  36. 36.
    Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41(5):1167–74.CrossRefPubMedGoogle Scholar
  37. 37.
    Iwashyna TJ, Odden A, Rohde J, Bonham C, Kuhn L, Malani P, et al. Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis. Med Care. 2014;52(6):e39–43.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Wilhelms SB, Huss FR, Granath G, Sjoberg F. Assessment of incidence of severe sepsis in Sweden using different ways of abstracting International Classification of Diseases codes: difficulties with methods and interpretation of results. Crit Care Med. 2010;38(6):1442–9.CrossRefPubMedGoogle Scholar
  39. 39.
    Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012;12(12):919–24.CrossRefPubMedGoogle Scholar
  40. 40.
    Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35(5):1244–50.CrossRefPubMedGoogle Scholar
  41. 41.
    Wang HE, Shapiro NI, Angus DC, Yealy DM. National estimates of severe sepsis in United States emergency departments. Crit Care Med. 2007;35(8):1928–36.CrossRefPubMedGoogle Scholar
  42. 42.
    Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis. Crit Care Med. 2014;42(3):625–31.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312(25):1604–8.CrossRefPubMedGoogle Scholar
  44. 44.
    Iwashyna TJ, Angus DC. Declining case fatality rates for severe sepsis: good data bring good news with ambiguous implications. JAMA. 2014;311(13):1295–7.CrossRefPubMedGoogle Scholar
  45. 45.
    Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med. 2012;40(3):754–61.CrossRefPubMedGoogle Scholar
  46. 46.
    Lindenauer PK, Lagu T, Shieh MS, Pekow PS, Rothberg MB. Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003–2009. JAMA. 2012;307(13):1405–13.CrossRefPubMedGoogle Scholar
  47. 47.
    Hall WB, Willis LE, Medvedev S, Carson SS. The implications of long-term acute care hospital transfer practices for measures of in-hospital mortality and length of stay. Am J Respir Crit Care Med. 2012;185(1):53–7.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Kumar G, Kumar N, Taneja A, Kaleekal T, Tarima S, McGinley E, et al. Nationwide trends of severe sepsis in the 21st century (2000–2007). Chest. 2011;140(5):1223–31.CrossRefPubMedGoogle Scholar
  49. 49.
    Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA. 2014;311(13):1308–16.CrossRefPubMedGoogle Scholar
  50. 50.
    Wood KA, Angus DC. Pharmacoeconomic implications of new therapies in sepsis. Pharmacoeconomics. 2004;22(14):895–906.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Division of Pulmonary, Critical Care, and Sleep MedicineAlpert/Brown Medical SchoolProvidenceUSA

Personalised recommendations